series-a
Stage
4
Investors
About
Synendos Therapeutics is a clinical-stage neuroscience company developing therapies to treat neuropsychiatric disorders by targeting the Endocannabinoid System, focusing on conditions like General Anxiety Disorder and Post-Traumatic Stress Disorder.
Explore Synendos's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.